Company
Kenai Therapeutics
| Industry | biotechnology company leveraging induced pluripotent stem cell (iPSC) technology |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Kenai Therapeutics | Series A | 2024-02-29 |
Company
| Industry | biotechnology company leveraging induced pluripotent stem cell (iPSC) technology |
|---|
| Company | Round | Date |
|---|---|---|
| Kenai Therapeutics | Series A | 2024-02-29 |